skip to main content
Hide All The Ads With a Yearly Membership Subscribe ▶

H.R. 1076: Preventing the Financing of Illegal Synthetic Drugs Act

React to this bill with an emoji

(About Ads | Hide These Ads)

To require the Comptroller General of the United States to carry out a study on the trafficking into the United States of synthetic drugs, and related illicit finance, and for other purposes.

The bill’s titles are written by its sponsor.

Sponsor and status

Photo of sponsor Mónica De La Cruz

Mónica De La Cruz

Sponsor. Representative for Texas's 15th congressional district. Republican.

Thumbnail of bill text
Read Text »
Last Updated: Jul 25, 2024
Length: 3 pages
Introduced
Feb 17, 2023
118th Congress (2023–2025)
Status

Passed House & Senate (President next) on Jul 23, 2024

This bill was passed by Congress on July 23, 2024 and goes to the President next.

Other activity may have occurred on another bill with identical or similar provisions.

Cosponsors

8 Cosponsors (5 Republicans, 3 Democrats)

Prognosis
80% chance of being enacted (details)
Source
Congress.gov
(About Ads | Hide These Ads)

History

Feb 17, 2023
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Read Text »

Feb 28, 2023
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Read Updated Text » See Changes »

May 16, 2023
 
Text Published

Updated bill text was published as of Preprint (Suspension).

Read Updated Text » See Changes »

May 22, 2023
 
Passed House (Senate next)

The bill was passed in a vote in the House. It goes to the Senate next.

thumbnail image of vote View Vote » Read Updated Text » See Changes »

May 22, 2023
 
Reported by House Committee on Financial Services

A committee issued a report on the bill, which often provides helpful explanatory background on the issue addressed by the bill and the bill's intentions.

Read Report »

Jul 23, 2024
 
Passed Senate

The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was by Unanimous Consent so no record of individual votes was made.

Read Updated Text » See Changes »

If this bill has further action, the following steps may occur next:
—
 
Signed by the President

H.R. 1076 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number H.R. 1076. This is the one from the 118th Congress.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 1076 — 118th Congress: Preventing the Financing of Illegal Synthetic Drugs Act.” www.GovTrack.us. 2023. August 22, 2024 <https://www.govtrack.us/congress/bills/118/hr1076>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.